Cerus (CERS) Cash from Discontinued Operations (2013 - 2014)
Cerus' (CERS) quarterly Cash from Discontinued Operations came in at 9825000.0 in Q1 2014, down 17.64% year-on-year from 11928826.86 in Q1 2013, and down 17.64% quarter-over-quarter from 8352000.0 in Q1 2013.
Cerus (CERS) Cash from Discontinued Operations (2013 - 2014) Analysis & Trends
Cerus has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting 9825000.0 for Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | -9.83 Mn |
| Mar 31, 2014 | -9.83 Mn |
| Mar 31, 2013 | -8.35 Mn |
| Mar 31, 2013 | -8.35 Mn |